Overview

Sleep Trial to Prevent Alzheimer's Disease

Status:
Not yet recruiting

Trial end date:
2025-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if treatment with the sleep aid suvorexant can decrease the rate of amyloid-β (Aβ) accumulation in the brain.

Phase:

Phase 2

Details

Lead Sponsor:

Washington University School of Medicine

Treatments:

Suvorexant